JPMorgan International Research Enhanced Equity Fund is a registered fund series of JPMorgan Trust II (series S000003653). Net assets $5.0B as of 2022-04-30.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| JPMorgan Prime Money Market Fund | — | $204.9M | 412.91% |
| Nestle SA | — | $143.5M | 289.19% |
| JPMorgan Securities Lending Money Market Fund | — | $127.3M | 256.64% |
| Roche Holding AG | — | $120.0M | 241.96% |
| ASML Holding NV | — | $99.5M | 200.59% |
| Novo Nordisk A/S | — | $95.4M | 192.38% |
| LVMH Moet Hennessy Louis Vuitton SE | — | $87.3M | 176.05% |
| Novartis AG | — | $83.8M | 168.92% |
| AstraZeneca plc | — | $77.9M | 156.96% |
| JPMorgan U.S. Government Money Market Fund | — | $73.6M | 148.28% |
| Diageo plc | — | $69.6M | 140.25% |
| BP plc | — | $63.5M | 127.96% |
| Allianz SE | — | $62.7M | 126.38% |
| TotalEnergies SE | — | $62.6M | 126.15% |
| L'Oreal SA | — | $62.5M | 125.93% |
| Report date | Net assets |
|---|---|
| 2022-04-30 | $5.0B |
| 2022-01-31 | $4.8B |
| 2021-10-31 | $5.0B |
| 2021-07-31 | $5.0B |
| 2021-04-30 | $4.9B |
| 2021-01-31 | $5.3B |
| 2020-10-31 | $4.9B |
| 2020-07-31 | $5.1B |